The Effectiveness of Low Level Laser Therapy on Particular Joint Points and Acupuncture Points on Knee Joints in Grade III Knee Osteoarthritis (LLLT OA)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Adnan Afzal, PhD*
- Phone Number: + 92 3085389670
- Email: adnanafzal@Hotmail.com
Study Contact Backup
- Name: Muhammad Hanif Ramlee, PhD
- Phone Number: +60 75558480
- Email: muhammad.hanif.ramlee@biomedical.utm.my
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan
- Recruiting
- Central Park Teaching Hospital
-
Contact:
- Maryam, MBBS
- Phone Number: +92 3014789648
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pain in the knee joint ( minimum 30/100 on VAS )
- Kellgren-Lawrence Grade III knee OA
ACR criteria for knee OA with radiological findings including ;
- age 35 and above
- joint crepitus
- less than 30 minutes of morning stiffness
Exclusion Criteria:
- Knee OA grade other than III.
Any contraindication of LLLT including;
- pregnancy
- carcinoma involving knee area
- Steroids and NSAIDS use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Particular joint point group
This group will receive laser irradiation on 6-7 particular points including 4-5 on tibiofemoral and 2 on patellofemoral joint.
|
Omega XP is the particular device producing low level laser therapy and has been in use for therapeutic purposes to treat different musculoskeletal conditions.
Other Names:
|
|
Experimental: Acupuncture points group
This group will receive laser irradiation on 6-7 particular acupuncture points which have been previously used in another study and or identified in literature.
|
Omega XP is the particular device producing low level laser therapy and has been in use for therapeutic purposes to treat different musculoskeletal conditions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Western Ontario and McMaster University Osteoarthritis Index ( WOMAC )
Time Frame: Baseline
|
Western Ontario and McMaster University Osteoarthritis Index is a standard questionnaire used in knee OA to assess the outcome of an intervention.
It's 24 items scale which covers pain, stiffness and function.
The score ranges from 0-96.
0 means the best health or best performance and 96 is the worst health status or performance.
|
Baseline
|
|
Western Ontario and McMaster University Osteoarthritis Index ( WOMAC )
Time Frame: 2nd week
|
Western Ontario and McMaster University Osteoarthritis Index is a standard questionnaire used in knee OA to assess the outcome of an intervention.
It's 24 items scale which covers pain, stiffness and function.
The score ranges from 0-96.
0 means the best health or best performance and 96 is the worst health status or performance.
|
2nd week
|
|
Western Ontario and McMaster University Osteoarthritis Index ( WOMAC )
Time Frame: 3rd week
|
Western Ontario and McMaster University Osteoarthritis Index is a standard questionnaire used in knee OA to assess the outcome of an intervention.
It's 24 items scale which covers pain, stiffness and function.
The score ranges from 0-96.
0 means the best health or best performance and 96 is the worst health status or performance.
|
3rd week
|
|
Western Ontario and McMaster University Osteoarthritis Index ( WOMAC )
Time Frame: 4th week
|
Western Ontario and McMaster University Osteoarthritis Index is a standard questionnaire used in knee OA to assess the outcome of an intervention.
It's 24 items scale which covers pain, stiffness and function.
The score ranges from 0-96.
0 means the best health or best performance and 96 is the worst health status or performance.
|
4th week
|
|
Western Ontario and McMaster University Osteoarthritis Index ( WOMAC )
Time Frame: 16th week
|
Western Ontario and McMaster University Osteoarthritis Index is a standard questionnaire used in knee OA to assess the outcome of an intervention.
It's 24 items scale which covers pain, stiffness and function.
The score ranges from 0-96.
0 means the best health or best performance and 96 is the worst health status or performance.
|
16th week
|
|
Timed Up and Go test ( TUG )
Time Frame: Baseline
|
Timed Up and Go test assesses the balance and is widely used in the clinical outcomes assessment.
It's measured in seconds.
Lesser the time means good balance and longer the time means poor balance.
|
Baseline
|
|
Timed Up and Go test ( TUG )
Time Frame: 2nd week
|
Timed Up and Go test assesses the balance and is widely used in the clinical outcomes assessment.
It's measured in seconds.
Lesser the time means good balance and longer the time means poor balance.
|
2nd week
|
|
Timed Up and Go test ( TUG )
Time Frame: 3rd week
|
Timed Up and Go test assesses the balance and is widely used in the clinical outcomes assessment.
It's measured in seconds.
Lesser the time means good balance and longer the time means poor balance.
|
3rd week
|
|
Timed Up and Go test ( TUG )
Time Frame: 4th week
|
Timed Up and Go test assesses the balance and is widely used in the clinical outcomes assessment.
It's measured in seconds.
Lesser the time means better performance and longer the time means poor performance.
|
4th week
|
|
Timed Up and Go test ( TUG )
Time Frame: 16th week
|
Timed Up and Go test assesses the balance and is widely used in the clinical outcomes assessment.
It's measured in seconds.
Lesser the time means good balance and longer the time means poor balance.
|
16th week
|
|
Visual Analog Scale ( VAS )
Time Frame: Baseline
|
Visual Analog Scale is a widely used tool to assess pain in knee OA.
The score ranges from 0-100.
0 means no pain and 100 means the worst pain.
|
Baseline
|
|
Visual Analog Scale ( VAS )
Time Frame: 2nd week
|
Visual Analog Scale is a widely used tool to assess pain in knee OA.
The score ranges from 0-100.
0 means no pain and 100 means the worst pain.
|
2nd week
|
|
Visual Analog Scale ( VAS )
Time Frame: 3rd week
|
Visual Analog Scale is a widely used tool to assess pain in knee OA.
The score ranges from 0-100.
0 means no pain and 100 means the worst pain.
|
3rd week
|
|
Visual Analog Scale ( VAS )
Time Frame: 4th week
|
Visual Analog Scale is a widely used tool to assess pain in knee OA.
The score ranges from 0-100.
0 means no pain and 100 means the worst pain.
|
4th week
|
|
Visual Analog Scale ( VAS )
Time Frame: 16th week
|
Visual Analog Scale is a widely used tool to assess pain in knee OA.
The score ranges from 0-100.
0 means no pain and 100 means the worst pain.
|
16th week
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Adnan Afzal, PhD, University of Technology Malaysia
Publications and helpful links
General Publications
- Hegedus B, Viharos L, Gervain M, Galfi M. The effect of low-level laser in knee osteoarthritis: a double-blind, randomized, placebo-controlled trial. Photomed Laser Surg. 2009 Aug;27(4):577-84. doi: 10.1089/pho.2008.2297.
- Bjordal JM, Couppe C, Chow RT, Tuner J, Ljunggren EA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother. 2003;49(2):107-16. doi: 10.1016/s0004-9514(14)60127-6.
- Al Rashoud AS, Abboud RJ, Wang W, Wigderowitz C. Efficacy of low-level laser therapy applied at acupuncture points in knee osteoarthritis: a randomised double-blind comparative trial. Physiotherapy. 2014 Sep;100(3):242-8. doi: 10.1016/j.physio.2013.09.007. Epub 2013 Nov 15.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Admin/GDEC/276/20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.